A study for advanced stage gall bladder cancer patients who are not fit to receive chemotherapy
Phase 2
Completed
- Conditions
- Health Condition 1: C23- Malignant neoplasm of gallbladder
- Registration Number
- CTRI/2019/04/018860
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 105
Inclusion Criteria
cytologically/pathologically confirmed Gall bladder cancer patients with poor performance status with adequate marrow and organ function,adjuvant chemotherapy if given should have been completed more than six months ago
Exclusion Criteria
Active malignancy other than biliary tract cancer,impaired liver function tests despite biliary drainage,lactating and pregnant women,previous exposure to Erlotinib or Capecitabine within six months,HIV positive patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method